QDEL
Quidelortho Corp
NASDAQ · Health Care
$29.10
+0.41 (+1.43%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 2.81B | 2.39B | 292.17M | 258.71M | 249.59M |
| Net Income | -2,074,337,216 | -1,583,597,840 | 31.23M | 28.36M | 24.50M |
| EPS | — | — | — | — | — |
| Profit Margin | -73.7% | -70.1% | 10.7% | 11.0% | 9.8% |
| Rev Growth | +17.9% | +17.9% | +22.1% | -5.1% | +22.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 448.88M | 448.88M | 985.55M | 916.37M | 939.18M |
| Total Equity | 539.52M | 539.52M | 894.58M | 833.27M | 835.00M |
| D/E Ratio | 0.83 | 0.83 | 1.10 | 1.10 | 1.12 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -1,783,807,593 | -1,437,456,284 | 40.94M | 36.02M | 39.52M |
| Free Cash Flow | — | — | 36.61M | 26.06M | 18.27M |